Key points
- Revenues from ordinary activities decreased by 21.0% to $1,592,466
- Loss from ordinary activities after tax decreased by 15.4% to $(6,101,158)
- No dividends paid, recommended, or declared during the current financial period
- Significant milestones achieved in commercialization and market expansion
- Strategic partnerships and collaborations expanded across various sectors
Full summary
HITIQ Ltd's FY2026 Annual Report reveals a 21% decline in revenues to $1,592,466 and a 15.4% reduction in losses to $(6,101,158). Despite these financial challenges, the company made significant strides in commercializing its concussion management technology. Key highlights include the national retail rollout of PROTEQT™ through Rebel, a world-first partnership with Sportscover for insurance integration, and expanded collaborations with universities and sporting organizations. The company also secured funding and government support, and welcomed new board members to strengthen its governance and strategic direction. While acknowledging challenges such as regulatory timelines and funding demands, HITIQ Ltd remains focused on converting validation into commercial success and growing recurring revenue.
Guidance
Revenues down 21.0%, loss down 15.4%, no dividends declared for FY2026
Outlook
HITIQ Ltd is optimistic about its position to capitalize on emerging opportunities in defense, universities, insurance, and retail markets, aiming to convert validation into sustained commercial success.